Ocular manifestations of allergies – options for self-treatment

Česká verze

Authors: Martina Čudová; Jana Melicharová; Tereza Kauerová
Authors place of work: Ústav farmakologie a toxikologie, Farmaceutická fakulta Masarykovy univerzity, Brno
Published in the journal: Čes. slov. Farm., 2026; 75, 48-53
Category: Samoléčba
doi: https://doi.org/10.36290/csf.2026.009

Summary

Ocular allergies, the majority of which are seasonal allergic conjunctivitis, are one of the most common ocular conditions for which patients seek professional help. These allergies mainly affect the structures of the anterior segment of the eye, including the conjunctiva, cornea, eyelids, or lacrimal glands. Patients may experience a range of symptoms, from mild to severe, and in some cases, chronic forms of the condition can lead to gradual vision impairment. Currently, several over-the-counter medications containing antihistamines, mast cell stabilizers, and decongestants are available for the treatment of ocular allergies, when used in combination with non-pharmacological and preventive measures. In terms of dosage form, topical preparations in the form of eye drops or systemic oral treatment can be chosen. Particularly, systemic oral treatment is usually preferred in chronic cases, with frequent exacerbations, or when the simultaneous occurrence of other allergic diseases, such as allergic rhinitis, is present. To reduce the ocular manifestations of allergies, the use of selected medical devices is also recommended, for example, those containing ectoine and hyaluronate which form a protective layer on the surface of the eye, thereby reducing the risk of irritation.

Keywords:

self-treatment – antihistamines – allergic conjunctivitis – over-the-counter medicines

Zdroje

1. Papadopoulos NG, Agache I, Bavbek S, et al. Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy. 2012 Nov 2;2(1):21.

2. Státní zdravotní ústav. Systém monitorování zdravotního stavu obyvatelstva ve vztahu k životnímu prostředí: Výsledky Studie zdraví dětí 2016. [Internet]. 2017. [cited 2026 Feb 02]. Available from: https://szu.gov.cz/wp-content/uploads/2022/12/Alergie_deti_2016.pdf

3. Patel DS, Arunakirinathan M, Stuart A, et al. Allergic eye disease. BMJ. 2017;359:j4706.

4. Dupuis P, Prokopich CL, Hynes A, et al. A contemporary look at allergic conjunctivitis. Allergy Asthma Clin Immunol. 2020 Jan 21;16(1):5.

5. Jutel M, Agache I, Zemelka-Wiacek M, et al. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper. Allergy. 2023 Nov;78(11):2851-2874.

6. Bartůňková J, Šedivá A, Kayserová J. Alergie a autoimunita –⁠ jin a jang imunopatologie. Alergie. 2006; 8(2):107-116.

7. Prokopich LC, Lee-Poy M, Kim H. Interprofessional Management of Allergic Conjunctivitis: A Proposed Algorithm for Canadian Clinical Practice. Can J Optom. 2018 Nov 6;80(3):11-27.

8. Bruschi G, Ghiglioni DG, Cozzi L, et al. Vernal Keratoconjunctivitis: A Systematic Review. Clin Rev Allergy Immunol. 2023 Aug;65(2):277-329.

9. Leonardi A, Righetti G, Giovannini G, et al. Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol. 2023 Oct 1;23(5):390-396.

10. Donshik PC, Ehlers WH, Ballow M. Giant Papillary Conjunctivitis. Immunol Allergy Clin North Am. 2008 Feb;28(1):83-103.

11. Odehnal M, Petrušková D, Malec J. Alergické konjunktivitidy u dětí. Pediatr. praxi. 2014;15(2):79-82.

12. Feuermannová A. Oční symptomy alergika a jejich léčba. Interní Med. 2012;14(4):165-168.

13. Xiao Z, Meng N, Zhou M, et al. New advances in the treatment of common conjunctivitis: A review. Health Nexus: Interdis Med Res J. 2025 Nov 15;1 : 22-30.

14. del Cuvillo A, Sastre J, Montoro J, et al. Allergic Conjunctivitis and H1 Antihistamines. J Investig Allergol Clin Immunol. 2009;19 Suppl 1 : 11-8.

15. Bystroň J. Antihistaminika v léčbě alergického zánětu. Remedia. 2014;24 : 272-278.

16. Randall KL, Hawkins CA. Antihistamines and allergy. Aust Prescr. 2018 Apr;41(2):41-45.

17. Seberová E. Antihistaminika v léčbě alergických chorob. Remedia [Internet]. 2009 Apr 20. [cited 2025 Dec 12] Available from: https://www.remedia.cz/rubriky/prehledy-komentare-nazory-diskuse/antihistaminika-v-lecbe-alergickych-chorob-811.

18. Kunešová V. Antihistaminika indikovaná k systémové a topické léčbě. Farm. praxi. 2020;16(2):67-73.

19. Dou XY, Zhang W. Topical ketotifen treatment for allergic conjunctivitis: a systematic review and Meta-analysis. Int J Ophthalmol. 2023;16(2):286-292.

20. Götzlová H. Bilastin -⁠ lékový profil. Farmakoterapeut. rev. [Internet]. 2021. [cited 2025 Dec 03] Available from: https://farmakoterapeutickarevue.cz/cs/bilastin-lekovy-profil.

21. Naqvi A, Patel P, Gerriets V. Cetirizine. In: StatPearls [Internet]. 2024 May 6. [cited 2025 Dec 03] Available from: http://www.ncbi.nlm.nih.gov/books/NBK549776/.

22. Doležal T, Vnoučková K. Levocetirizinum. Remedia [Internet]. 2009 Apr 09. [cited 2025 Nov 25] Available from: https://www.remedia.cz/rubriky/lekove-profily/levocetirizinum-760/.

23. Štrofová H, Sedláček K, Netuková M, et. al. Oční alergie. Prakt. Lékáren. 2013;9(4-5):165-172.

24. Finn DF, Walsh JJ. Twenty-first century mast cell stabilizers. Br J Pharmacol. 2013 Sep;170(1):23-37.

25. Salapatek AM, Werkhäuser N, Ismail B, et al. Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis. Clin Transl Allergy. 2021;11(1):e12006.

26. Hynnekleiv L, Magno M, Vernhardsdottir RR, et al. Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol. 2022 Dec;100(8):844-860.

27. Sala A, Recio MC, Giner RM, et al. Anti-inflammatory and antioxidant properties of Helichrysum italicum. J Pharm Pharmacol. 2002 Mar;54(3):365-371.

28. Urgacz A, Mrukwa E, Gawlik R. Adverse events in allergy sufferers wearing contact lenses. Postepy Dermatol Alergol. 2015 Jun;32(3):204-209.

29. Hakkarainen JJ, Reinisalo M, Ragauskas S, et al. Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells. Int J Pharm. 2016 Sep;511(1):73-78.

30. Rath A, Eichhorn M, Träger K, et al. In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells. Ann Anat. 2019 Mar;222 : 129-138.

31. Zemanová M, Matušková V. Přínos a kontraproduktivita terapie kortikosteroidy u afekcí rohovky. Čes. Slov. Oftalmol. 2017;73(2):69-77.

32. Petrů V. Novinky v alergenové imunoterapii. Interní Med. 2017;19(2):78-81.

33. SÚKL. Databáze léků SÚKL [Internet]. [cited 2025 Dec 14]. Available from: https://prehledy.sukl.cz/prehled_leciv.html#/.